Immuto Scientific is a biotechnology services company that provides analytical insights to pharmaceutical companies for drug discovery.
Pyran LLC specializes in developing a starting compound for the production of paints and plastic chemicals. Founded in 2017 and based in Madison, Wisconsin, the company creates a diol product derived from renewable wood and crop waste resources. This diol serves as a raw material for various applications, including digital versatile discs, paints, bottles, coatings, plastics, ropes, glues, and adhesives. Pyran primarily caters to the chemical industries, focusing on sustainable solutions for paint and plastic manufacturing.
Asto CT LLC specializes in X-ray computed tomography (CT) technology designed to enhance the health and safety of horses, particularly thoroughbreds, show horses, and older equines. Founded in 2015 and based in Madison, Wisconsin, the company focuses on improving fracture risk detection, diagnosing lameness, and managing dental and sinus issues. Its innovative system allows for rapid 3D imaging of the lower limbs, head, and neck of standing horses without the need for general anesthesia, ensuring a safer and more comfortable experience for the animals. Asto CT aims to provide high-quality volumetric imaging to improve equine well-being and offer reassurance to horse owners, while pioneering advancements in robotics and multi-slice CT technology for more effective screening and diagnosis.
OnLume, Inc. is a medical device company based in Madison, Wisconsin, founded in 2015. The company specializes in developing intuitive and ergonomic solutions for fluorescence image-guided surgery, aiming to enhance surgical precision in both human and veterinary medicine. OnLume is dedicated to providing surgeons with high-quality images in well-lit surgical environments. The company is currently testing prototypes in collaboration with the Laboratory for Optical and Computational Imaging (LOCI) and the Morgridge Institute for Research, both located in Madison. However, the systems have not yet received FDA clearance for market release and are not available for sale.
LÜM is a startup based in Madison that has developed a streaming music platform and social network aimed at promoting emerging artists. The platform focuses on helping local and up-and-coming musicians grow their fan bases by emphasizing new music over established talents. By removing traditional barriers to music discovery, LÜM seeks to reduce the disparity in exposure between corporate music and independent artists. This approach allows users to discover fresh music while enabling artists to monetize their talents and engage with fans throughout their careers.
LÜM is a social media, music discovery, and streaming application that allows fans to directly support their favorite emerging artists. The company's application focuses on up and coming artists around the world and provides the ability for users to discover, share, and circulate music. They seek to decrease the disparity in exposure between corporate music and new music, and link-local areas into the undiscovered music that is all around them. By rethinking the interaction between social media and streaming, LÜM will eventually become a live entertainment “talent pool” for up and coming music around the world.
At PROMISS Diagnostics they take applied science seriously. We believe marrying basic science with cutting-edge analytics can unleash exponential diagnostic potential from otherwise common blood tests. Their team is passionate about driving change and helping more people find hope by developing innovative diagnostic tools that are efficacious, inexpensive, and accessible to all.
SimpleMachines, Inc. is a semiconductor design and development company based in Madison, Wisconsin, established in 2016. It specializes in creating a Software-Defined Compute platform that addresses the evolving demands of artificial intelligence, virtual reality, machine learning, robotics, and big data. As traditional computing systems face limitations due to the end of Moore's Law and the increasing complexity of software, SimpleMachines offers a programmable platform that allows for real-time hardware optimization. This innovative approach contrasts with conventional single-purpose systems, which are costly, time-consuming to develop, and often become obsolete upon deployment. The company's platform enables software developers to enhance application performance by dynamically reconfiguring hardware, thus supporting a wide range of use cases and ensuring adaptability in rapidly changing technological environments.
HealthMyne, Inc., a healthcare informatics company, provides novel search, analytics, and imaging solutions to healthcare enterprises. It focuses on providing solutions to cancer care providers. The company’s smart imaging solutions deliver clinical decision support and quality assurance services to reduce diagnostic errors and increase clinical collaboration. Its technology provides physicians with tumor image manipulation, and EHR and image repository search capabilities for diagnosing and treating similar cases. HealthMyne, Inc. was founded in 2013 and is based in Madison, Wisconsin.
SimpleMachines, Inc. is a semiconductor design and development company based in Madison, Wisconsin, established in 2016. It specializes in creating a Software-Defined Compute platform that addresses the evolving demands of artificial intelligence, virtual reality, machine learning, robotics, and big data. As traditional computing systems face limitations due to the end of Moore's Law and the increasing complexity of software, SimpleMachines offers a programmable platform that allows for real-time hardware optimization. This innovative approach contrasts with conventional single-purpose systems, which are costly, time-consuming to develop, and often become obsolete upon deployment. The company's platform enables software developers to enhance application performance by dynamically reconfiguring hardware, thus supporting a wide range of use cases and ensuring adaptability in rapidly changing technological environments.
FluGen, Inc. is a biopharmaceutical company focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007 and based in Madison, Wisconsin, FluGen offers RedeeFlu, a nasal spray vaccine designed to protect against influenza, along with a vaccine-loaded intradermal microneedle delivery device. The company aims to address both seasonal and pandemic influenza on a global scale.
Isomark, LLC is a company based in Madison, Wisconsin, established in 2005, that specializes in non-invasive breath monitoring technology aimed at detecting life-threatening infections. Its primary product, Canary, functions as a breath analyzer that measures and analyzes isotopic biomarkers present in exhaled CO2 samples. This technology enables healthcare providers to monitor personal health and identify disease states effectively. Isomark's approach facilitates the early detection and treatment of infections, including hospital-related conditions like sepsis, thereby allowing for timely medical intervention before illnesses progress to more serious or chronic stages. The company's solutions are applicable in various clinical settings, including primary disease detection and outpatient medical services, as well as post-operative patient monitoring.
HealthMyne, Inc., a healthcare informatics company, provides novel search, analytics, and imaging solutions to healthcare enterprises. It focuses on providing solutions to cancer care providers. The company’s smart imaging solutions deliver clinical decision support and quality assurance services to reduce diagnostic errors and increase clinical collaboration. Its technology provides physicians with tumor image manipulation, and EHR and image repository search capabilities for diagnosing and treating similar cases. HealthMyne, Inc. was founded in 2013 and is based in Madison, Wisconsin.
Isomark, LLC is a company based in Madison, Wisconsin, established in 2005, that specializes in non-invasive breath monitoring technology aimed at detecting life-threatening infections. Its primary product, Canary, functions as a breath analyzer that measures and analyzes isotopic biomarkers present in exhaled CO2 samples. This technology enables healthcare providers to monitor personal health and identify disease states effectively. Isomark's approach facilitates the early detection and treatment of infections, including hospital-related conditions like sepsis, thereby allowing for timely medical intervention before illnesses progress to more serious or chronic stages. The company's solutions are applicable in various clinical settings, including primary disease detection and outpatient medical services, as well as post-operative patient monitoring.
FluGen, Inc. is a biopharmaceutical company focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007 and based in Madison, Wisconsin, FluGen offers RedeeFlu, a nasal spray vaccine designed to protect against influenza, along with a vaccine-loaded intradermal microneedle delivery device. The company aims to address both seasonal and pandemic influenza on a global scale.
Isomark, LLC is a company based in Madison, Wisconsin, established in 2005, that specializes in non-invasive breath monitoring technology aimed at detecting life-threatening infections. Its primary product, Canary, functions as a breath analyzer that measures and analyzes isotopic biomarkers present in exhaled CO2 samples. This technology enables healthcare providers to monitor personal health and identify disease states effectively. Isomark's approach facilitates the early detection and treatment of infections, including hospital-related conditions like sepsis, thereby allowing for timely medical intervention before illnesses progress to more serious or chronic stages. The company's solutions are applicable in various clinical settings, including primary disease detection and outpatient medical services, as well as post-operative patient monitoring.
Holos, Inc. is an educational technology company that provides a spatial computing platform designed for immersive learning experiences in 3D environments. Founded in 2015 and based in Madison, Wisconsin, Holos enables teachers and students to create, organize, and interact with content in a virtual reality space, resembling a 3D version of PowerPoint. Users can integrate various media types, including photos, videos, text, and 3D models, into their learning environments. The platform features tools such as 3D object and content cards, a collaborative magic table for spatial presentations, and a content library with pre-vetted 3D learning experiences, all of which facilitate active, hands-on learning. Holos operates on desktop VR headsets, making it accessible for educational settings.
FluGen, Inc. is a biopharmaceutical company focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007 and based in Madison, Wisconsin, FluGen offers RedeeFlu, a nasal spray vaccine designed to protect against influenza, along with a vaccine-loaded intradermal microneedle delivery device. The company aims to address both seasonal and pandemic influenza on a global scale.
Madison Vaccines, Inc., a biopharmaceutical company, develops therapeutic plasmid DNA vaccines. It focuses on bone metastases and prostate cancer. The company is based in United States.
Isomark, LLC is a company based in Madison, Wisconsin, established in 2005, that specializes in non-invasive breath monitoring technology aimed at detecting life-threatening infections. Its primary product, Canary, functions as a breath analyzer that measures and analyzes isotopic biomarkers present in exhaled CO2 samples. This technology enables healthcare providers to monitor personal health and identify disease states effectively. Isomark's approach facilitates the early detection and treatment of infections, including hospital-related conditions like sepsis, thereby allowing for timely medical intervention before illnesses progress to more serious or chronic stages. The company's solutions are applicable in various clinical settings, including primary disease detection and outpatient medical services, as well as post-operative patient monitoring.
Madison Vaccines, Inc., a biopharmaceutical company, develops therapeutic plasmid DNA vaccines. It focuses on bone metastases and prostate cancer. The company is based in United States.
Silatronix, Inc. is a company based in Madison, Wisconsin, specializing in the development of organosilicon (OS) compounds and formulations for energy storage applications. Founded in 2007, the company focuses on creating organosilicon electrolytes used in both rechargeable and non-rechargeable lithium-ion batteries, as well as in ultracapacitors. Silatronix combines expert knowledge in organosilicon chemistry with advancements in nanostructured electrodes and the electronic properties of materials, aimed at enhancing the performance and efficiency of energy storage devices. Its innovative products are integral to the evolving landscape of energy storage technology.
NeuWave Medical develops tools that deliver energy to the human body to treat a variety of serious medical conditions. Their company founders are both engineers and physician-scientists which allows determining a clinical need and design solutions that are clinically relevant, effective, and minimally invasive. They strive to make the highest quality devices that are the products of choice for leading physicians and medical centers around the world. The company was founded in 2004 and is headquartered in Madison, Wisconsin.
Cellular Dynamics International Inc., (CDI) is a developer and manufacturer of fully functioning cells in industrial quantities to precise specifications. CDI's proprietary products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell Products). CDI's products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our products, among other purposes, for drug discovery and screening, to test the safety and efficacy of their small molecule and biological drug candidates, for stem cell banking, and in the research and development of cellular therapeutics.
NeuWave Medical develops tools that deliver energy to the human body to treat a variety of serious medical conditions. Their company founders are both engineers and physician-scientists which allows determining a clinical need and design solutions that are clinically relevant, effective, and minimally invasive. They strive to make the highest quality devices that are the products of choice for leading physicians and medical centers around the world. The company was founded in 2004 and is headquartered in Madison, Wisconsin.
Deltanoid Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the research, development, and commercialization of therapies for the treatment of renal diseases, osteoporosis, skin diseases, and other targets. It focuses on vitamin D analogs and other compounds to develop selected therapies through early phases of the drug development process. The company’s product includes DP001 for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease receiving hemodialysis. It also develops DP006 for the treatment of acne. The company was founded in 1999 and is based in Madison, Wisconsin.
Mithridion is a biopharmaceutical company that discovers and develops drugs for central nervous system disorders, with an initial focus on Alzheimer's disease and schizophrenia.
Roche NimbleGen provides products and services to the life science research market. The company offers SeqCap EZ system, a solution-based capture system that enables enrichment of exome in a single test tube; SeqCap EZ library that covers exome designs, gene panels, and custom content designs; and SeqCap EZ reagents to maximize workflow and order different reagent needs. It also provides SeqCap Epi, an enrichment system that includes a set of target enrichment tools for DNA methylation assessment at single-base resolution, as well as offers SeqCap Epi kits and reagents. The company provides a set of preparation and adapter kits for library construction including SignalMap, a software product for browsing of genomic tracks; and NimbleDesign, an online tool that enables users to design SeqCap EZ choice libraries. It offers DNA microarray products and services for CGH, ChIP-chip, DNA methylation, AccuSNP, CGS, instruments, sequence capture arrays, gene expression microarrays, and their associated workflows. The company also provides online technical and instruction support services. Roche NimbleGen was founded in 1999 and is headquartered in Madison, Wisconsin. As of August 8, 2007, Roche NimbleGen operates as a subsidiary of Roche Holding AG.
Roche NimbleGen provides products and services to the life science research market. The company offers SeqCap EZ system, a solution-based capture system that enables enrichment of exome in a single test tube; SeqCap EZ library that covers exome designs, gene panels, and custom content designs; and SeqCap EZ reagents to maximize workflow and order different reagent needs. It also provides SeqCap Epi, an enrichment system that includes a set of target enrichment tools for DNA methylation assessment at single-base resolution, as well as offers SeqCap Epi kits and reagents. The company provides a set of preparation and adapter kits for library construction including SignalMap, a software product for browsing of genomic tracks; and NimbleDesign, an online tool that enables users to design SeqCap EZ choice libraries. It offers DNA microarray products and services for CGH, ChIP-chip, DNA methylation, AccuSNP, CGS, instruments, sequence capture arrays, gene expression microarrays, and their associated workflows. The company also provides online technical and instruction support services. Roche NimbleGen was founded in 1999 and is headquartered in Madison, Wisconsin. As of August 8, 2007, Roche NimbleGen operates as a subsidiary of Roche Holding AG.